Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A practical approach to render tuberculosis samples safe for application of tuberculosis molecular bacterial load assay in clinical settings without a biosafety level 3 laboratory.
Mtafya B, Qwaray P, John J, Sichone E, Shoo A, Gillespie SH, Ntinginya NE, Sabiiti W. Mtafya B, et al. Among authors: ntinginya ne. Tuberculosis (Edinb). 2023 Jan;138:102275. doi: 10.1016/j.tube.2022.102275. Epub 2022 Nov 15. Tuberculosis (Edinb). 2023. PMID: 36434867 Free article.
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials.
Musisi E, Wyness A, Eldirdiri S, Dombay E, Mtafya B, Ntinginya NE, Heinrich N, Kibiki GS, Hoelscher M, Boeree M, Aarnoutse R, Gillespie SH, Sabiiti W; PanACEA consortium. Musisi E, et al. Among authors: ntinginya ne. Lancet Microbe. 2023 Nov;4(11):e913-e922. doi: 10.1016/S2666-5247(23)00191-X. Epub 2023 Oct 10. Lancet Microbe. 2023. PMID: 37832571 Free article.
Clinical-demographic markers for improving diabetes mellitus diagnosis in people with tuberculosis in Tanzania.
Byashalira KC, Chamba NG, Alkabab Y, Mbelele PM, Ntinginya NE, Ramaiya KL, Alimohamed MZ, Heysell SK, Mmbaga BT, Bygbjerg IC, Christensen DL, Mpagama SG, Lillebaek T; ADEPT Consortium. Byashalira KC, et al. Among authors: ntinginya ne. BMC Infect Dis. 2022 Mar 16;22(1):260. doi: 10.1186/s12879-022-07249-x. BMC Infect Dis. 2022. PMID: 35296241 Free PMC article.
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043-02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial.
Heinrich N, de Jager V, Dreisbach J, Gross-Demel P, Schultz S, Gerbach S, Kloss F, Dawson R, Narunsky K, Matt L, Wildner L, McHugh TD, Fuhr U, Aldana BH, Mouhdad C, Brake LT, Boeree MJ, Aarnoutse RE, Svensson EM, Gong X, P J Phillips P, Diacon AH, Hoelscher M; PanACEA-TB consortium. Heinrich N, et al. Lancet Microbe. 2024 Dec 26:100952. doi: 10.1016/j.lanmic.2024.07.015. Online ahead of print. Lancet Microbe. 2024. PMID: 39793592 Free article.
N-acetylcysteine modulates markers of oxidation, inflammation and infection in tuberculosis.
Mapamba DA, Sabi I, Lalashowi J, Sauli E, Buza J, Olomi W, Mtafya B, Kibona M, Bakuli A, Rachow A, Velen K, Hoelscher M, Ntinginya NE, Charalambous S, Churchyard G, Wallis RS; TB SEQUEL consortium. Mapamba DA, et al. Among authors: ntinginya ne. J Infect. 2025 Jan 3;90(2):106379. doi: 10.1016/j.jinf.2024.106379. Online ahead of print. J Infect. 2025. PMID: 39756697 Free article.
Optimizing delivery strategies for 3HP TB preventive treatment in Tanzania: A qualitative study on acceptability of family approach in HIV care and treatment centers.
Pamba D, Sanga E, Mlalama K, Maganga L, Mangu C, Lwilla A, Olomi W, Minja LT, Sabi I, Kisonga R, Matechi E, Jelly I, Neema P, Rwebembera A, Aboud S, Ntinginya NE. Pamba D, et al. Among authors: ntinginya ne. PLOS Glob Public Health. 2024 Dec 17;4(12):e0003142. doi: 10.1371/journal.pgph.0003142. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39689067 Free PMC article.
Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB.
Naidoo K, Naidoo A, Abimiku AG, Tiemersma EW, Gebhard A, Hermans SM, Sloan DJ, Ruhwald M, Georghiou SB, Okpokoro E, Agbaje A, Yae K, Tollera G, Moga S, Feyt H, Kachoka T, Letsoalo MP, Cabibbe AM, Perumal R, Shunmugam L, Cirillo DM, Foraida S, Sabiiti W, Ntinginya NE, Mtafya B, Bedru A, Gillespie SH; TRiAD Study Consortium. Naidoo K, et al. Among authors: ntinginya ne. BMJ Open. 2024 Nov 27;14(11):e084722. doi: 10.1136/bmjopen-2024-084722. BMJ Open. 2024. PMID: 39609025 Free PMC article.
Performance of stool-based molecular tests and processing methods for paediatric tuberculosis diagnosis: a systematic review and meta-analysis.
Carratalà-Castro L, Munguambe S, Saavedra-Cervera B, de Haas P, Kay A, Marcy O, Nabeta P, Ssengooba W, Ghimenton-Walters E, Acácio S, Bonnet M, Ehrlich J, DiNardo AR, Vasiliu A, Lange C, Hermans S, Mandalakas AM, López-Varela E, García-Basteiro AL; Stool4TB Global Partnership. Carratalà-Castro L, et al. Lancet Microbe. 2024 Nov 9:100963. doi: 10.1016/j.lanmic.2024.100963. Online ahead of print. Lancet Microbe. 2024. PMID: 39547244 Free article.
Impact of point-of-care birth test-and-treat on clinical outcomes among infants with HIV: A cluster randomized trial in Mozambique and Tanzania.
Jani IV, Sabi I, Elsbernd K, Meggi B, Mahumane A, Lwilla AF, Pereira K, Boniface S, Edom R, Lequechane J, Chale F, Chiwerengo N, Ntinginya NE, Mudenyanga C, Mueller M, Rauscher M, Hoelscher M, Taveira N, Buck WC, Kroidl A; LIFE study consortium. Jani IV, et al. Among authors: ntinginya ne. Clin Infect Dis. 2024 Nov 8:ciae530. doi: 10.1093/cid/ciae530. Online ahead of print. Clin Infect Dis. 2024. PMID: 39514367
103 results